Genomic Study Analysis TruRisk Panel v3 - MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 - Germany

MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht - Downloaded Version 2027.0.0-ballot.1 See the Directory of published versions

Example Procedure: Genomic Study Analysis TruRisk Panel v3

English

Profiles: MII PR MolGen Genomic Study Analysis, https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/genomic-study-analysis|2027.0.0-ballot.1

Genomic Study Analysis Specimen: Specimen: identifier = https://www.charite.de/fhir/sid/bioproben#specimen_03; status = available; type = Tissue specimen from breast (specimen); receivedTime = 2022-11-01

Genomic Study Analysis Device
device: Device: status = active; manufacturer = Illumina

Genomic Study Analysis Method Type: Sequencing

Genomic Study Analysis Regions
description: TruRisk Panel v3: Alle kodierenden Exons der Core-Gene für erblichen Brust- und Eierstockkrebs
studied: ATM
studied: BRCA1
studied: BARD1
studied: BRCA2
studied: BRIP1
studied: CDH1
studied: CHEK2
studied: MLH1
studied: MSH2
studied: MSH6
studied: PALB2
studied: PMS2
studied: PTEN
studied: RAD51C
studied: RAD51D
studied: TP53

status: Completed

category: Laboratory

subject: Elisa Schmidt-Huber (official) Female, DoB: 1973-03-12 ( Medical record number (use: usual, ))

IG © 2021+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.molgen#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-13
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.